Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In-stent restenosis is associated with proliferative skin healing and specific immune and endothelial cell profiles: results from the RACHEL trial.

Frontiers in immunology - 1 Jan 2023

Lozano Íñigo, Bangueses Roi, Rodríguez Isabel, Pevida Marta, Rodríguez-Aguilar Raúl, Rodríguez Diana, Espasandín-Arias Martina, Llames Sara, Meana Álvaro, Suárez Ana, Rodríguez-Carrio Javier

Abstract excerpt

Introduction: In-stent restenosis (ISR) is a major challenge in interventional cardiology. Both ISR and excessive skin healing are aberrant hyperplasic responses, which may be functionally related. However, the cellular component underlying ISR remains unclear, especially regarding vascular homeostasis. Recent evidence suggest that novel immune cell populations may be involved in vascular repair and damage, but...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronary Restenosis
Share to Endothelial Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Stents

Source

Open in PubMed Open full text

Identifiers

PMID: 37325628
DOI: 10.3389/fimmu.2023.1138247
PMCID: PMC10265483

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In-stent restenosis is associated with proliferative skin healing and specific immune and endothelial cell profiles: results from the RACHEL trial.PMID 37325628Read ↗

Immune-Mediated Coronary Stent Failure: From PCI-Induced Vascular Injury to In-Stent Restenosis, Neoatherosclerosis and Stent ThrombosisSemantic proximity Read ↗

Longitudinal <i>in vivo</i> human wound healing model defines key role for smooth muscle cells in ECM remodelingSemantic proximity Read ↗

Microparticles from ISR patients participate in vascular intimal hyperplasia by promoting oxidative stress, inflammation and adhesion through ERK and P38 pathwaysSemantic proximity Read ↗

Integrative multiomics analysis of neointima proliferation in human saphenous vein: implications for bypass graft diseaseSemantic proximity Read ↗

Human Saphenous Vein Ex Vivo Culture as a Translational Model of Intimal HyperplasiaSemantic proximity Read ↗

Inflammatory Phenotype by OCT Coronary Imaging: Specific Features Among De Novo Lesions, In-Stent Neointima, and In-Stent Neo-Atherosclerosis.Semantic proximity Read ↗

Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.Semantic proximity Read ↗

A systematic review and bioinformatic study on clinical, paraclinical, and genetic factors predisposing to stent restenosis following percutaneous coronary intervention.Semantic proximity Read ↗

Cellular composition of human early and advanced coronary atherosclerotic lesionsSemantic proximity Read ↗

Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validationSemantic proximity Read ↗

Endothelial damage and stem cell repair in atherosclerosisSemantic proximity Read ↗

Immunomodulatory endothelial cells contribute to T cell recruitment and activation through antigen presentation on MHC class IISemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.